ESR1 and breast carcinoma: To establish whether or not these sites were occupied in vivo, we carried out chromatin immunoprecipitation (ChIP) experiments using the ER+ breast cancer cell lines HCC70 and T47D, which are homozygous for the minor and the common FGFR2 alleles, respectively.